Ubs Group Ag Biote Corp. Transaction History
Ubs Group Ag
- $528 Billion
- Q1 2025
A detailed history of Ubs Group Ag transactions in Biote Corp. stock. As of the latest transaction made, Ubs Group Ag holds 14,068 shares of BTMD stock, worth $54,583. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,068
Previous 103,845
86.45%
Holding current value
$54,583
Previous $650,000
92.92%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding BTMD
# of Institutions
89Shares Held
16.9MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY4.55MShares$17.6 Million7.37% of portfolio
-
Bandera Partners LLC New York, NY2.44MShares$9.45 Million2.95% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$6.23 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.41MShares$5.48 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA701KShares$2.72 Million0.01% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $29.4M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...